Showing results (761-770 of 932) with videos related to

Sort By:
Pageof 94
Hypertension (Dallas, Tex. : 1979)|November 5, 2003
Plasma homocysteine, hypertension incidence, and blood pressure tracking: the Framingham Heart StudyJohan Sundström, Lisa Sullivan, Ralph B D'Agostino, et al.
The Journal of Nutrition|November 11, 2003
Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Study CohortGiuseppina T Russo, Simonetta Friso, Paul F Jacques, et al.
Familial Cancer|December 19, 2018
A squamous cell carcinoma in a young woman with Lynch syndromeF Adan, M B Crijns, E Dekker, et al.
Genomics|November 1, 1991
Evidence for genetic heterogeneity in malignant hyperthermia susceptibilityR C Levitt, N Nouri, A E Jedlicka, et al.
European Journal of Cancer (Oxford, England : 1990)|August 10, 2000
Modulation of drug resistance by alpha-tubulin in paclitaxel-resistant human lung cancer cell linesE K Han, E Kyu-Ho Han, L Gehrke, et al.
Archivos Latinoamericanos De Nutricion|September 1, 1978
[Use of tests based on the analysis of expired air in nutritional studies]N W Solomons, R E Schneider, R García Ibáñez, et al.
Biochemistry|February 6, 2004
Pseudosubstrate peptides inhibit Akt and induce cell growth inhibitionYan Luo, Richard A Smith, Ran Guan, et al.
Archives of Neurology|May 14, 2008
Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring StudySudha Seshadri, Philip A Wolf, Alexa S Beiser, et al.
The Journal of Biological Chemistry|November 7, 2002
Survivin enhances Aurora-B kinase activity and localizes Aurora-B in human cellsJun Chen, Sha Jin, Stephen K Tahir, et al.
Journal of Medicinal Chemistry|February 19, 1993
Studies directed toward the design of orally active renin inhibitors. 2. Development of the efficacious, bioavailable renin inhibitor (2S)-2-benzyl-3- [[(1-methylpiperazin-4-yl)sulfonyl]propionyl]-3-thiazol-4-yl-L-alanine amide of (2S,3R,4S)-2-amino-1-cyclohexyl-3,4-dihydroxy-6-methylheptane (A-72517)S H Rosenberg, K P Spina, S L Condon, et al.
Pageof 94